ImmuCell Basic EPS 2010-2024 | ICCC
ImmuCell basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| ImmuCell Annual Basic EPS | |
|---|---|
| 2023 | $-0.75 |
| 2022 | $-0.32 |
| 2021 | $-0.01 |
| 2020 | $-0.14 |
| 2019 | $-0.19 |
| 2018 | $-0.42 |
| 2017 | $-0.03 |
| 2016 | $0.12 |
| 2015 | $0.40 |
| 2014 | $-0.06 |
| 2013 | $0.04 |
| 2012 | $0.03 |
| 2011 | $-0.14 |
| 2010 | $-0.13 |
| 2009 | $-0.07 |
| ImmuCell Quarterly Basic EPS | |
|---|---|
| 2024-09-30 | $-0.09 |
| 2024-06-30 | $-0.20 |
| 2024-03-31 | $-0.06 |
| 2023-12-31 | $-0.15 |
| 2023-09-30 | $-0.12 |
| 2023-06-30 | $-0.18 |
| 2023-03-31 | $-0.30 |
| 2022-12-31 | $-0.22 |
| 2022-09-30 | $-0.08 |
| 2022-06-30 | $-0.09 |
| 2022-03-31 | $0.07 |
| 2021-12-31 | $0.01 |
| 2021-09-30 | $0.02 |
| 2021-06-30 | $0.02 |
| 2021-03-31 | $-0.06 |
| 2020-12-31 | $0.03 |
| 2020-09-30 | $-0.04 |
| 2020-06-30 | $-0.11 |
| 2020-03-31 | $-0.02 |
| 2019-12-31 | $-0.06 |
| 2019-09-30 | $-0.07 |
| 2019-06-30 | $-0.09 |
| 2019-03-31 | $0.03 |
| 2018-12-31 | $-0.18 |
| 2018-09-30 | $-0.05 |
| 2018-06-30 | $-0.15 |
| 2018-03-31 | $-0.04 |
| 2017-12-31 | $-0.03 |
| 2017-09-30 | $-0.07 |
| 2017-06-30 | $-0.05 |
| 2017-03-31 | $0.12 |
| 2016-12-31 | $-0.01 |
| 2016-09-30 | $0.01 |
| 2016-06-30 | $0.00 |
| 2016-03-31 | $0.12 |
| 2015-12-31 | $0.09 |
| 2015-09-30 | $0.12 |
| 2015-06-30 | $0.03 |
| 2015-03-31 | $0.16 |
| 2014-12-31 | $0.04 |
| 2014-09-30 | $0.00 |
| 2014-06-30 | $-0.10 |
| 2014-03-31 | $0.00 |
| 2013-12-31 | $-0.05 |
| 2013-09-30 | $0.02 |
| 2013-06-30 | $0.00 |
| 2013-03-31 | $0.07 |
| 2012-12-31 | $-0.01 |
| 2012-09-30 | $-0.02 |
| 2012-06-30 | $0.01 |
| 2012-03-31 | $0.05 |
| 2011-12-31 | |
| 2011-09-30 | $-0.04 |
| 2011-06-30 | $-0.09 |
| 2011-03-31 | $-0.01 |
| 2010-12-31 | $0.04 |
| 2010-09-30 | $-0.07 |
| 2010-06-30 | $0.00 |
| 2010-03-31 | $-0.02 |
| 2009-12-31 | $-0.01 |
| 2009-09-30 | $-0.01 |
| 2009-06-30 | $-0.05 |
| 2009-03-31 | $-0.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.046B | $0.017B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.174B | 28.29 |
| Boston Scientific (BSX) | United States | $155.945B | 42.10 |
| Stryker (SYK) | United States | $148.251B | 31.87 |
| EssilorLuxottica (ESLOY) | France | $140.098B | 0.00 |
| Medtronic (MDT) | Ireland | $111.559B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.232B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.180B | 29.35 |
| GE HealthCare Technologies (GEHC) | United States | $42.309B | 20.61 |
| Agilent Technologies (A) | United States | $39.127B | 25.93 |
| ResMed (RMD) | United States | $34.442B | 26.53 |
| Terumo (TRUMY) | Japan | $26.591B | 37.81 |
| Koninklijke Philips (PHG) | Netherlands | $23.545B | 16.81 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.572B | 12.92 |
| Insulet (PODD) | United States | $19.899B | 79.24 |
| Baxter (BAX) | United States | $15.736B | 10.24 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.201B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.927B | 37.20 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.944B | 27.52 |
| Lantheus Holdings (LNTH) | United States | $5.659B | 13.15 |
| Prestige Consumer Healthcare (PBH) | United States | $4.205B | 20.07 |
| ICU Medical (ICUI) | United States | $4.019B | 38.26 |
| Envista Holdings (NVST) | United States | $3.747B | 29.81 |
| Perrigo (PRGO) | Ireland | $3.383B | 9.96 |
| Haemonetics (HAE) | United States | $3.198B | 15.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.913B | 19.63 |
| QuidelOrtho (QDEL) | United States | $2.817B | 23.67 |
| LeMaitre Vascular (LMAT) | United States | $2.319B | 56.37 |
| Neogen (NEOG) | United States | $2.232B | 25.73 |
| AtriCure (ATRC) | United States | $1.907B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.89 |
| InMode (INMD) | Israel | $1.349B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.296B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.211B | 8.65 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.030B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.979B | 15.01 |
| Evolus (EOLS) | United States | $0.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.918B | 0.00 |
| CeriBell (CBLL) | United States | $0.794B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.686B | 0.00 |
| Valneva SE (VALN) | France | $0.613B | 0.00 |
| Omeros (OMER) | United States | $0.536B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.527B | 4.12 |
| Surmodics (SRDX) | United States | $0.491B | 0.00 |
| SNDL (SNDL) | Canada | $0.465B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.438B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 31.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.341B | 0.00 |
| Cerus (CERS) | United States | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.318B | 57.90 |
| Viemed Healthcare (VMD) | United States | $0.315B | 30.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.301B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.294B | 19.70 |
| Biote (BTMD) | United States | $0.266B | 5.83 |
| Canopy Growth (CGC) | Canada | $0.260B | 0.00 |
| Zynex (ZYXI) | United States | $0.239B | 50.13 |
| Sanuwave Health (SNWV) | United States | $0.236B | 3.31 |
| Brainsway (BWAY) | Israel | $0.213B | 113.20 |
| High Tide (HITI) | Canada | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.40 |
| MacroGenics (MGNX) | United States | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.167B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 17.65 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 13.08 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Exagen (XGN) | United States | $0.068B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.060B | 30.83 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.052B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.049B | 14.17 |
| INLIF (INLF) | $0.046B | 0.00 | |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |